abstract |
The present invention generally includes an isolated antibody specifically binding to human CD137, a pharmaceutical composition and method of use thereof, a nucleic acid comprising a nucleotide sequence encoding the antibody, a vector comprising the nucleic acid, the nucleic acid or the vector It relates to a host cell, and a method for producing the antibody. |